Oruka Therapeutics Stock (NASDAQ:ORKA)
Previous Close
$67.74
52W Range
$8.91 - $71.00
50D Avg
$46.01
200D Avg
$29.27
Market Cap
$2.59B
Avg Vol (3M)
$759.53K
Beta
-0.61
Div Yield
$19.36
ORKA Company Profile
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.